HCID 59214162, compound → HCID 86645556, compound
Reaction equation
Br[C:2]1[N:6]([CH2:7][CH2:8][O:9][CH2:10][CH2:11][O:12][CH2:13][CH2:14][F:15])[C:5]2[CH:16]=[CH:17][CH:18]=[CH:19][C:4]=2[N:3]=1.[CH3:20][N:21]([C:29]1[CH:34]=[CH:33][C:32]([C:35]#[CH:36])=[CH:31][CH:30]=1)[C:22](=[O:28])[O:23][C:24]([CH3:27])([CH3:26])[CH3:25]>>[F:15][CH2:14][CH2:13][O:12][CH2:11][CH2:10][O:9][CH2:8][CH2:7][N:6]1[C:5]2[CH:16]=[CH:17][CH:18]=[CH:19][C:4]=2[N:3]=[C:2]1[C:36]#[C:35][C:32]1[CH:31]=[CH:30][C:29]([N:21]([CH3:20])[C:22](=[O:28])[O:23][C:24]([CH3:25])([CH3:27])[CH3:26])=[CH:34][CH:33]=1Participants
Procedure
T541 was prepared using general procedure B from 2-bromo-1-(2-(2-(2-fluoroethoxy)ethoxy)ethyl)-1H-benzo[d]imidazole and tert-butyl methyl-4-(ethynyl)phenylcarbamate. Reaction was performed on a 72 mgs scale of 2-bromo-1-(2-(2-(2-fluoroethoxy)ethoxy)ethyl)-1H-benzo[d]imidazole. The crude product was purified by ISCO column to afford tert-butyl 4-((1-(2-(2-(2-fluoroethoxy)ethoxy)ethyl)-1H-benzo[d]imidazol-2-yl)ethynyl)phenyl(methyl)carbamate (0.02 g, 19.21%). It was then dissolved in acetonitrile (1.0 mL). To this solution was added 20% Sulfuric acid (1.0 mL, 3.75 mmol). The reaction mixture was stirred at room temperature for 30 mins. The crude product was purified by prep HPLC to afford T541 TFA salt (0.004 g, 19.44%). 1H NMR (400 MHz, CD3CN) δ 7.78-7.76 (m, 1H), 7.70-7.68 (m, 1H), 7.51-7.45 (m, 4H), 6.66-6.64 (m, 2H), 4.63-4.60 (m, 2H), 4.44-4.42 (m, 1H), 4.32-4.30 (m, 1H), 3.95-3.92 (m, 2H), 3.57-3.53 (m, 3H), 3.48-3.45 (m, 3H), 2.82 (m, 3H). MS (ESI): 382.1 (M+H+).
Workup
- customT541 was prepared
- customReaction
- customThe crude product was purified by ISCO column
Sources & evidence
- ORD record
- ord-3c7e17e5bc494a879a5642e2a917ef2b
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691187B2
Reaction notes
Loading…